New clues in puzzle over pre-eclampsia and cholesterol regulation

21 Jun 2017 12:09:03.313

PA 139/17

Scientists studying a mystery link between the dangerous pregnancy complication pre-eclampsia and an increased risk of heart disease in later life for both mother and child have uncovered important new clues.

A study, led by researchers at the University of Nottingham, appears to suggest that the body’s normal defence mechanism of flushing out damaging cholesterol from the blood may be disrupted by the illness.

The results of the study, published in the June edition of the Journal of Lipid Research, show that although the mother’s body attempts to compensate and offset the effect of higher cholesterol levels, this damage limitation fails because the placenta has already been compromised by the disease.

Click here for full story

It has prompted the researchers to undertake a further study monitoring mothers with pre-eclampsia after delivery to investigate whether their ability to effectively remove excess cholesterol from their cells in the weeks following birth continues to be disrupted.

If so, it could pave the way for tests which could identify those women most at risk of developing heart disease and who may benefit from receiving preventative advice and medication.

Useful indicator

Dr Hiten Mistry, British Heart Foundation Intermediate Basic Science Research Fellow in the University’s School of Medicine, led the study. He said: “This is a very interesting finding and illustrates the importance of having the correct balance of cholesterol during pregnancy. The ability of mothers to effectively remove excess cholesterol is essential and monitoring this after delivery in women who suffered from pre-eclampsia could prove to be a useful indicator to identify those individuals at high risk of early heart disease.”

Pre-eclampsia is one of the leading causes of serious illness and death in pregnant women worldwide, affecting between two and eight per cent of pregnancies.

It usually affects women in the second half of pregnancy or soon after their baby is delivered. Early signs of pre-eclampsia include high blood pressure and protein in the urine. While many cases are mild, in more serious cases it can lead to complications for the mother including blood clotting disorders, organ failure and seizures, while babies can be smaller and born prematurely.

Both women who develop pre-eclampsia and their babies are at increased risk of high blood pressure and heart disease in later life. Mothers affected are also eight times more likely to develop heart disease, while their babies are five times more likely to be affected.

Fail safe system

During pregnancy, it is important for the fetus to receive some cholesterol from its mother to aid its growth and development and build basic fat reserves.

However, excessive amounts can be damaging and the body works to strip away surplus cholesterol by carrying it away in the blood to the liver where it is processed and recycled.

The placenta too plays a role – as well as providing the baby with oxygen and essential nutrients, it also helps to regulate the amount of cholesterol which is passed to the unborn child.

However, the study found that in pre-eclampsia, both the mother’s system for removing the cholesterol from the body and the placental fail safe system were both compromised by the disease.

The study, Increased Maternal and Fetal Cholesterol Efflux Capacity and Placental CYP27A1 Expression in Preeclampsia, was carried out in collaboration with academics at the University of Bern in Switzerland and King’s College London.

— Ends —

Our academics can now be interviewed for broadcast via our Media Hub, which offers a Globelynx fixed camera and ISDN line facilities at University Park campus. For further information please contact a member of the Communications team on +44 (0)115 951 5798, email or see the Globelynx website for how to register for this service.

For up to the minute media alerts, follow us on Twitter

Notes to editors: 

The University of Nottingham is a research-intensive university with a proud heritage, consistently ranked among the world's top 100. Studying at the University of Nottingham is a life-changing experience and we pride ourselves on unlocking the potential of our 44,000 students - Nottingham was named University of the Year for Graduate Employment in the 2017 Times and Sunday Times Good University Guide, was awarded gold in the TEF 2017 and features in the top 20 of all three major UK rankings. We have a pioneering spirit, expressed in the vision of our founder Sir Jesse Boot, which has seen us lead the way in establishing campuses in China and Malaysia - part of a globally connected network of education, research and industrial engagement. We are ranked eighth for research power in the UK according to REF 2014. We have six beacons of research excellence helping to transform lives and change the world; we are also a major employer and industry partner - locally and globally.

Impact: The Nottingham Campaign, its biggest-ever fundraising campaign, is delivering the University’s vision to change lives, tackle global issues and shape the future. More news…


Story credits

More information is available from Dr Hiten Mistry in the Division of Child Health, Obstetrics & Gynaecology, School of Medicine, University of Nottingham on +44 (0)115 823 1897,

Emma Thorne Emma Thorne - Media Relations Manager

Email: Phone: +44 (0)115 951 5793 Location: University Park

Additional resources

No additional resources for this article

Media Relations - External Relations

The University of Nottingham
YANG Fujia Building
Jubilee Campus
Wollaton Road
Nottingham, NG8 1BB

telephone: +44 (0) 115 951 5798